Navigation Links
PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryx's Traficet-EN(TM) Presented in Oral Session at DDW 2009 Conference
Date:6/1/2009

. Additional clinical programs include the development of CCX140, which targets the CCR2 receptor, currently in a Phase I clinical trial and intended for subsequent development to treat diseases such as Type 2 diabetes, multiple sclerosis and vascular restenosis, and CCX354, a CCR1 antagonist in a Phase I clinical trial, being developed for inflammatory diseases such as rheumatoid arthritis. ChemoCentryx also has several programs in preclinical development. ChemoCentryx is privately held. For more information, please refer to www.chemocentryx.com.

Any statements in this press release about ChemoCentryx's expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and are forward-looking statements. These statements are often, but not always, made through the use of words or phrases such as may, believe, will, expect, anticipate, estimate, intend, predict, seek, potential, continue, plan, should, could and would or the negative of these terms or other comparable terminology. Forward-looking statements are not guarantees of performance. They involve known and unknown risks, uncertainties and assumptions that may cause actual results, levels of activity, performance or achievements to differ materially from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to (i) the initiation, timing, progress and results of ChemoCentryx's preclinical studies and clinical trials, (ii) ChemoCentryx's ability to advance product candidates into clinical trials, (iii) GSK's exercise of its license options, (iv) the commercialization of ChemoCentryx's product candidates, (v) the implement
'/>"/>

SOURCE ChemoCentryx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
2. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
3. Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
4. Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL)
5. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
6. TNFerade(TM) Phase III Data Presented at ASCO
7. Ironwood and Forest Present Additional Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation
8. Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
9. Proteolix Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 ASCO Annual Meeting
10. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
11. Semafores SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, Is Well Tolerated and Demonstrates Activity in Phase I Solid Tumor Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... YORK , Sept. 1, 2014 ... is available in its catalogue:  Drug Discovery ... http://www.reportlinker.com/p02349116/Drug-Discovery-Technologies---A-Global-Market-Overview.html The ... such as cancer requires extensive expenditure, in addition ... step in designing a new drug involves the ...
(Date:8/30/2014)... Aug. 30, 2014   Royal Philips  (NYSE: PHG, ... a new ultrasound system designed to enable global ... increasing patient volumes and cost pressures. Making its debut ... in Barcelona this week, Affiniti ... patients with fewer resources deliver high quality patient care. ...
(Date:8/29/2014)... Aug. 29, 2014 The Competitive Intelligence (CI) ... marketplace changes. CI leaders who adjust will succeed, and ... a new Best Practices, LLC study CI leaders from ... including: - Use secondary research whenever possible ... - Internal staff who are creative thinkers ...
Breaking Medicine Technology:Drug Discovery Technologies - A Global Market Overview 2Drug Discovery Technologies - A Global Market Overview 3Drug Discovery Technologies - A Global Market Overview 4Drug Discovery Technologies - A Global Market Overview 5Drug Discovery Technologies - A Global Market Overview 6Drug Discovery Technologies - A Global Market Overview 7Drug Discovery Technologies - A Global Market Overview 8Drug Discovery Technologies - A Global Market Overview 9Drug Discovery Technologies - A Global Market Overview 10Drug Discovery Technologies - A Global Market Overview 11Drug Discovery Technologies - A Global Market Overview 12Drug Discovery Technologies - A Global Market Overview 13Drug Discovery Technologies - A Global Market Overview 14Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2
... 2007 -,Icagen, Inc. (NASDAQ: ICGN) announced today that ... Committee,("DMC") of the Company's ASSERT trial of senicapoc ... in adults, the,DMC recommended that the trial be ... reduction in crisis rate, the primary,endpoint. In making ...
... Inc. announced today that it will have multiple,presentations ... on April 14-18 in Los Angeles. These presentations,will ... oncology,programs including its lead tyrosine kinase inhibitor compound,MP470 ... protein target involved,in cancer cell drug resistance. Presentations ...
Cached Medicine Technology:Icagen Terminates Phase III ASSERT Study 2Icagen Terminates Phase III ASSERT Study 3SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 2SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 3SuperGen to Highlight Oncology Pipeline Data in Multiple,Presentations at AACR 4
(Date:9/1/2014)... D.C. (PRWEB) September 01, 2014 The ... pleased to announce that Dawn Bazarko, DNP, MPH, RN, ... Fellows of the American Academy of Nursing. They will ... MBA, RN-BC, CCM, FACHE, whose induction we reported last ... October 18, 2014, during the 2014 American Academy of ...
(Date:9/1/2014)... 01, 2014 In honor of National Take Your ... Animal Emergency & Referral Center of Minnesota (AERC) is offering a ... for their cats. , Many people don’t take their cat to ... a hassle,” but they wouldn’t decide not to take their kid ... cavity. The same goes for pets. Just like people want their ...
(Date:9/1/2014)... Top10BestSEOHosting.com has recently compared many web ... carefully, Top10BestSEOHosting.com is here to announce that JustHost, ... suppliers in 2014. , JustHost ( http://www.justhost.com/track/seohosts ) ... shared hosting plan. The company’s approach to hosting ... affordable, accessible and powerful enough for anyone to ...
(Date:9/1/2014)... The Outlier Series announced the next short ... from one of the exceptional women featured in the ... Changers . The title of the upcoming mini e-Book ... McClendon . McClendon is currently a full-time physician’s assistant, ... of WeTV show, Raising Sextuplets. , Jenny was chosen ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Developers of FCPX ... tutorial video for the ProWorld Plugin from Pixel Film Studios. ... Pro X can do and users now have the ability ... Said Christina Austin, CEO of Pixel Film Studios. “Blurring the ... changer.” , Learn how to turn a 2D HDRI image ...
Breaking Medicine News(10 mins):Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:Pixel Film Studios Released a New Tutorial Entitled ProWorld Lesson Exclusively for Final Cut Pro X 2
... can help cut the pain, experts say , SUNDAY, Oct. 18 ... an injection, so it,s no surprise that children will try to ... flu shots this year. , "The good news is that ... their child,s experience when getting a needlestick -- whether it,s a ...
... Signs Proclamation , ORLANDO, Fla., Oct. 18 ... of Healthcare Quality Professionals in achieving improved patient care ... are driven by the desire to make a positive ... communities. They lead improvement changes not only through content ...
... 17 Nearly 40 local organizations will come together today ... Center to host the Celebrate Your Children, Celebrate You ... from 10:00 a.m. to 2:00 p.m. , As ... the need for local health and community services has never ...
... Iowa, Oct. 16 The announcement by the U.S. Department of ... three pigs from the Minnesota State Fair in August are the ... swine herd provides an opportunity to stress three important messages: , ... the H1N1 flu from eating pork. Pork and pork products remain ...
... 16 Certain cookie diets recently featured in the media ... apparent health benefits. Smart for Life Cookie Diet should not ... lifestyle featuring products that are all-natural, 60% organic, and filled ... a healthy lifestyle that has become much more than a ...
... , CHARLOTTESVILLE, Va., Oct. 16 The Focused Ultrasound ... Steve Rusckowski to its Board of Directors. , Mr. ... of Philips Healthcare in November, 2006, and has been ... April 2007. He was previously the CEO of the ...
Cached Medicine News:Health News:Florida Celebrates National Healthcare Quality Week 2Health News:Anthem Blue Cross Teams with Lowell Neighborhood Resource Center to Address Health and Wellness Needs in Fresno 2Health News:Smart for Life(TM) Cookie Diet Provides Nutrients 2Health News:Smart for Life(TM) Cookie Diet Provides Nutrients 3Health News:Philips Healthcare CEO Joins Focused Ultrasound Surgery Foundation Board of Directors 2Health News:Philips Healthcare CEO Joins Focused Ultrasound Surgery Foundation Board of Directors 3
... The HypercleanTM 2 ... especially for enclosing benchtop equipment. ... can fit comfortably inside the ... 2 fume containment system unit ...
Benchtop Fume Expeller is a low profile portable fume expeller that can be configured with up to 12 fans. The Benchtop Fume Expeller is available as a recirculating unit or can be attached to existi...
Surgical-grade stainless steel disposable concentric needle with Trocar tip has an insulated platinum-alloy core and two attached 61-cm (24-in) lead wires. Needles sold in packages of 20....
... B OIA test provides rapid detection ... from cervical or vaginal swabs from ... are unknown at the time of ... offers physicians additional information for patient ...
Medicine Products: